Loading…
ApoE [var epsilon]4 genotype and the age at onset of temporal lobe epilepsy: A case-control study and meta-analysis
In order to investigate the role of ApoE [var epsilon]4 as a modifier of the age at onset of temporal lobe epilepsy (TLE), we performed a molecular epidemiology study in 78 patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Genotyping was done by a PCR-RFLP assay. In order to bet...
Saved in:
Published in: | Epilepsy research 2010-08, Vol.90 (3), p.234-239 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In order to investigate the role of ApoE [var epsilon]4 as a modifier of the age at onset of temporal lobe epilepsy (TLE), we performed a molecular epidemiology study in 78 patients with mesial temporal lobe epilepsy and hippocampal sclerosis. Genotyping was done by a PCR-RFLP assay. In order to better estimate the role of this variant as a modifier of the age at onset, we also performed a systematic review of the literature. We included our results into a meta-analysis along with data available from seven published studies with 728 patients that looked into the role of ApoE [var epsilon]4 in TLE. We found that ApoE [var epsilon]4 carriers in our population had a non-significant earlier age of epilepsy onset than non-carriers. The meta-analysis confirmed this finding, showing that ApoE [var epsilon]4 carriers had epilepsy onset almost 4 years earlier than non-carriers (mean difference 5.15 years; CI 95% 2.08-6.22; p = 0.001). In conclusion, the ApoE [var epsilon]4 isoform is a genetic factor that might influence the age at onset of TLE. |
---|---|
ISSN: | 0920-1211 |
DOI: | 10.1016/j.eplepsyres.2010.05.007 |